Your browser doesn't support javascript.
loading
A Granulomatous Drug Eruption Induced by Entecavir
Annals of Dermatology ; : 493-495, 2013.
Article Dans Anglais | WPRIM | ID: wpr-123640
ABSTRACT
Entecavir (Baraclude(R), Bristol-Myers Squibb) is a potent and selective antiviral agent that has demonstrated efficacy in patients with chronic hepatitis B. The most frequent adverse events attributed to entecavir include increased alanine aminotransferase, upper respiratory tract infection, headache, abdominal pain, cough, pyrexia, fatigue, and diarrhea. Although quite a few randomized double-blind studies including ones investigating adverse events along with these general symptoms have been reported, few cases of cutaneous adverse events have been described in detail. We demonstrate a case of granulomatous drug eruption as a cutaneous adverse event induced by entecavir.
Sujets)

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Sujet Principal: Infections de l'appareil respiratoire / Douleur abdominale / Méthode en double aveugle / Toxidermies / Hépatite B chronique / Toux / Diarrhée / Alanine transaminase / Fatigue / Fièvre Type d'étude: Essai clinique contrôlé Limites du sujet: Humains langue: Anglais Texte intégral: Annals of Dermatology Année: 2013 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Sujet Principal: Infections de l'appareil respiratoire / Douleur abdominale / Méthode en double aveugle / Toxidermies / Hépatite B chronique / Toux / Diarrhée / Alanine transaminase / Fatigue / Fièvre Type d'étude: Essai clinique contrôlé Limites du sujet: Humains langue: Anglais Texte intégral: Annals of Dermatology Année: 2013 Type: Article